Gurupadaswamy, Handuvinahalli Devanna published the artcileSynthesis of Pyrimidones and Evaluation of Their Xanthine Oxidase Inhibitory and Antioxidant Activities, COA of Formula: C7H7IN2O, the publication is Archiv der Pharmazie (Weinheim, Germany) (2013), 346(11), 805-811, database is CAplus and MEDLINE.
The increasing prevalence of gout has been accompanied by a growing number of patients intolerant to or with disease refractory to the available urate-lowering therapies. This metabolic disease is a common disease with a higher prevalence in men older than 30 years and in women older than 50 years. These findings highlight the need for emerging treatments to effectively lower urate levels. In this view, we describe the xanthine oxidase (XO) inhibitory activities of the synthesized compounds I(R = Cl, Br, I, Me, tBu, OMe, CF3, OCF3, NO2, NMe2) and also their antioxidant activities. Compounds I(R = I, Me, OMe, OCF3, NMe2) exhibited good inhibitory activities against XO. On the other hand, compounds I(R = CF3, OCF3) exhibited moderate antioxidant activity.
Archiv der Pharmazie (Weinheim, Germany) published new progress about 39115-95-2. 39115-95-2 belongs to iodides-buliding-blocks, auxiliary class Iodide,Hydrazine,Amine,Benzene,Hydrazide,Amide, name is 4-Iodobenzohydrazide, and the molecular formula is C7H7IN2O, COA of Formula: C7H7IN2O.
Referemce:
https://en.wikipedia.org/wiki/Iodide,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com